Procalcitonin Doubling Time for Postoperative Monitoring of Medullary Thyroid Carcinoma: A Comparative Kinetic Analysis
Clinical Endocrinology · 2026
DOI: 10.1111/cen.70147 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Alfredo Campenni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Biomedical, Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Procalcitonin, Carcinoma, Neuroendocrine, Calcitonin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Calcitonin doubling time (CT‐DT) is an established prognostic tool in medullary thyroid carcinoma (MTC), yet CT measurement can be affected by analytical variability and assay interference. Procalcitonin (PCT) has shown promise as a complementary biomarker, but data on PCT doubling time (PCT‐DT) remain scarce.
Methods
Longitudinal CT and PCT were measured using Elecsys immunoassays in 25 MTC patients followed for up to 24 months after thyroidectomy. Doubling times were estimated using log‐linear regression and a rolling‐window approach. Agreement was assessed using Spearman correlation, Bland–Altman analysis, and Cohen's κ across predefined DT categories.
Results
CT and PCT kinetics showed clear separation across response categories. In progressive disease, CT‐DT and PCT‐DT were strongly correlated with minimal systematic bias and substantial categorical agreement ( κ = 0.76). Short DT values clustered in structural incomplete responders.
Conclusions
PCT‐DT closely mirrors CT‐DT and may serve as a complementary kinetic marker in the postoperative monitoring of MTC, particularly when CT interpretation is uncertain; however, these findings should be considered exploratory and warrant confirmation in larger prospective cohorts before clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Unit, Biomedical, Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy.
- Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
- School of Medicine, University of Zagreb, Zagreb, Croatia.
- Department of Surgery, Gruppo Ospedaliero Moncucco, Lugano, Switzerland.
- Medical School, University of Basel, Basel, Switzerland.
- Endocrinology Unit, Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Zitieren
APA
Campenni, A., Ovčariček, P. P., Posabella, A., Ruggeri, R. M., & Giovanella, L. (2026). Procalcitonin Doubling Time for Postoperative Monitoring of Medullary Thyroid Carcinoma: A Comparative Kinetic Analysis. Clinical Endocrinology. https://doi.org/10.1111/cen.70147
Vancouver
Campenni A, Ovčariček PP, Posabella A, Ruggeri RM, Giovanella L. Procalcitonin Doubling Time for Postoperative Monitoring of Medullary Thyroid Carcinoma: A Comparative Kinetic Analysis. Clinical Endocrinology. 2026. doi:10.1111/cen.70147
BibTeX
@article{Campenni2026,
author = {Campenni, Alfredo and Ovčariček, Petra Petranović and Posabella, Alberto and Ruggeri, Rosaria M and Giovanella, Luca},
title = {Procalcitonin Doubling Time for Postoperative Monitoring of Medullary Thyroid Carcinoma: A Comparative Kinetic Analysis},
journal = {Clinical Endocrinology},
year = {2026},
doi = {10.1111/cen.70147}
}
EUVIMED